A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

Clinical trial NCT07554924 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07554924
Sponsor: Lanyue Biotech (Hangzhou) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy 1

Start date: 2026-05-15
Primary completion: 2029-05-25
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.